Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin in Ulcerative Colitis
NCT06213857Phase 2Recruiting
- Sponsor
- Tanta University
- Start
- Feb 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silymarin in ulcerative colitis (UC), sponsored by Tanta University. Started Feb 2025; status: recruiting.
02
Drugs
silymarin
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06213857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06213857.